Document is current
Any future updates will be listed below
-
Authors
Sun, Maoyuan
Huang, Ning
Tao, Yihao
Wen, Rong
Zhao, Guanjian
Zhang, Xiang
Xie, Zongyi
Cheng, Yuan
Mao, Jinning
Liu, Guodong https://orcid.org/0000-0002-8048-2243
-
Funding
Funding for this research was provided by:
Chongqing Scientific and Health Joint Medical Research Project (2020GDRC021)
- License Information
-
More Information
Article History
Received: 2 November 2021
Accepted: 10 March 2022
First Online: 28 March 2022
Declarations
:
: The clinical trial has received ethical committee approval from the research ethics committee (REC) of the Second Affiliated Hospital of Chongqing Medical University (ID: LKSD-2020-214). Address: No. 76, Linjiangmen, Yuzhong District, Chongqing. Tel.: 026069338. Informed consent forms, describing the particular study procedures and illustrating the potential benefits and risks, will be provided to each patient. The investigator will introduce the protocol to the participants and explain in detail the harms and benefits of this trial according to informed consent. It will be voluntary for patients (or their families) to decide whether or not to participate in this study.
: All of the authors are willing to provide a model consent form on request.
: The authors declare that they have no competing interests.
